[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Dupuytren Contracture Global Clinical Trials Review, H1, 2019

May 2019 | 64 pages | ID: DDD72EC7C1FEN
GlobalData

US$ 2,500.00

Email Delivery - PDF (on default),
Hard Copy Mail Delivery (+US$ 190.00)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Dupuytren Contracture Global Clinical Trials Review, H1, 2019

SUMMARY

GlobalData's clinical trial report, “Dupuytren Contracture Global Clinical Trials Review, H1, 2019' provides an overview of Dupuytren Contracture clinical trials scenario. This report provides top line data relating to the clinical trials on Dupuytren Contracture. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

SCOPE
  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

REASONS TO BUY
  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Report Guidance
GlobalData Clinical Trials Report Coverage
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Clinical Trials by G7 Countries: Proportion of Dupuytren Contracture to Musculoskeletal Disorders Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Dupuytren Contracture Therapeutics Clinical Trials
Prominent Drugs
Clinical Trial Profile Snapshots
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

LIST OF TABLES

Dupuytren Contracture Therapeutics, Global, Clinical Trials by Region, 2019*
Dupuytren Contracture Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019*
Dupuytren Contracture Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019*
Dupuytren Contracture Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2019*
Dupuytren Contracture Therapeutics Clinical Trials, Europe, Top Five Countries, 2019*
Dupuytren Contracture Therapeutics Clinical Trials, North America, Top Countries, 2019*
Dupuytren Contracture Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2019*
Proportion of Dupuytren Contracture to Musculoskeletal Disorders Clinical Trials, G7 Countries (%), 2019*
Dupuytren Contracture Therapeutics, G7 Countries, Clinical Trials by Phase, 2019*
Dupuytren Contracture Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019*
Dupuytren Contracture Therapeutics, Global, Clinical Trials by Phase, 2019*
Dupuytren Contracture Therapeutics, Global, Clinical Trials In Progress by Phase 2019*
Dupuytren Contracture Therapeutics, Global, Clinical Trials by Trial Status, 2019*
Dupuytren Contracture Therapeutics Clinical Trials, Global, by End Point Status, 2019*
Dupuytren Contracture Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018
Dupuytren Contracture Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019*
Dupuytren Contracture Therapeutics Clinical Trials, Global, Key Sponsors, 2019*
Dupuytren Contracture Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019*
Dupuytren Contracture Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019*

LIST OF FIGURES

Dupuytren Contracture Therapeutics, Global, Clinical Trials by Region (%), 2019*
Dupuytren Contracture Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019*
Dupuytren Contracture Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019*
Dupuytren Contracture Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2019*
Dupuytren Contracture Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019*
Dupuytren Contracture Therapeutics Clinical Trials, North America, Top Countries (%), 2019*
Proportion of Dupuytren Contracture to Musculoskeletal Disorders Clinical Trials, G7 Countries (%), 2019*
Dupuytren Contracture Therapeutics, G7 Countries, Clinical Trials by Phase, 2019*
Dupuytren Contracture Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019*
Dupuytren Contracture Therapeutics, Global, Clinical Trials by Phase (%), 2019*
Dupuytren Contracture Therapeutics, Global, Clinical Trials In Progress by Phase, 2019*
Dupuytren Contracture Therapeutics, Global, Clinical Trials by Trial Status, 2019*
Dupuytren Contracture Therapeutics Clinical Trials, Global, by End Point Status, 2019*
Dupuytren Contracture Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018
Dupuytren Contracture Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019*
Dupuytren Contracture Therapeutics Clinical Trials, Global, Key Sponsors, 2019*
Dupuytren Contracture Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019*
Dupuytren Contracture Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019*
GlobalData Methodology

COMPANIES MENTIONED

Endo International Plc
Pfizer Inc
Novotech Australia Pty Ltd
BioSpecifics Technologies Corp
180 Therapeutics
Pacira BioSciences Inc
Nysora Inc
Medcare Oy
GWT-TUD GmbH
Asahi Kasei Corp


More Publications